Of the studies in biopsy confirmed NASH, plasma lipoparticle analyses by HPLC or ultracentrifugation have shown an increase in total triglycerides, VLDL, LDL, and ApoB100 and a decrease in HDL in NASH relative to normal livers [4]. The gene discussed is APOB; the disease is metabolic dysfunction-associated steatohepatitis.